Latest Industry News & Trends

Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.

Recently Added News

3/22/2024
BreakingEuropeRegulationRetina
Ophthalmic Bevacizumab Candidate from Outlook Gains Positive CHMP Opinion
Ophthalmic Bevacizumab Candidate from Outlook Gains Positive CHMP Opinion

Outlook Therapeutics announced March 22 that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) had issued a positive opinion recommending approval of ONS-5010 (L...

3/22/2024
BreakingDealsDry EyePharmaRevenueSurgical
2023 Ophthalmic Revenue Roundup for Harrow, Alimera Sciences, and EyePoint
2023 Ophthalmic Revenue Roundup for Harrow, Alimera Sciences, and EyePoint

Nashville, Tennessee-based Harrow reported March 19 that its 2023 revenue was $130.2 million, a 47 percent increase over $88.6 million in 2022. The company generated record quarterly revenue in Q4-...

3/22/2024
BreakingClinical TrialRetina
OcuTerra’s Eye Drop Candidate for DR Misses Endpoints in Phase II
OcuTerra’s Eye Drop Candidate for DR Misses Endpoints in Phase II

OcuTerra Therapeutics announced March 14 that nesvategrast (OTT166 5%), its eye drop candidate for diabetic retinopathy, did not meet its primary or key secondary efficacy endpoints in the Phase II...

3/21/2024
ChinaIndiaMeetingMyopiaNewsletter
2024 APAO Congress Brainstorms How to Expand Access to Eye Care; Companies Showcase Tech Boom
2024 APAO Congress Brainstorms How to Expand Access  to Eye Care; Companies Showcase Tech Boom

Nearly 7,800 delegates attended the 2024 congress of the Asia-Pacific Academy of Ophthalmology in southern Bali from Feb. 22-25. The 253 sessions and 120 exhibits spread across four floors in two n...

3/22/2024
BreakingRegulationRetina
Eylea HD, Izervay Get Billing J-Codes in the US
Eylea HD, Izervay Get Billing J-Codes in the US

The Centers for Medicare and Medicaid Services (CMS) has issued J-codes for Regeneron’s Eylea HD and Astellas Pharma’s Izervay. The billing codes take effect April 1, 2024. Eylea HD (aflibercept) i...

3/22/2024
BreakingFundingSurgical
Bascom Palmer Uses $1 Million Gift to Launch Whole Eye Transplant Initiative
Bascom Palmer Uses $1 Million Gift to Launch Whole Eye Transplant Initiative

Bascom Palmer Eye Institute reported March 5 that it would use a $1 million donation to fast-forward its initiative to transplant a whole eye. The hospital, part of the University of Miami, said th...

3/22/2024
BreakingDiagnosticFundraisingRetinaStudy
AI Has Perfect Detection Rate for Severe Cases of ROP in Study
AI Has Perfect Detection Rate for Severe Cases of ROP in Study

Artificial intelligence can accurately and independently detect 100 percent of severe cases of retinopathy of prematurity (ROP), according to a study published March 7 in the journal JAMA Ophthalmo...

3/22/2024
BreakingDry EyeIndustry
Amring Adopts Name Nordic Pharma Amid Ownership Change
Amring Adopts Name Nordic Pharma Amid Ownership Change

Amring Pharmaceuticals announced March 4 that it had changed its name to Nordic Pharma Inc., following the change in ownership of the company from Sever Life Sciences to Nordic Group in June 2023. ...

3/22/2024
BreakingCataractIOLIndiaSurgical
Alcon Launches Clareon PC-IOLs in India
Alcon Launches Clareon PC-IOLs in India

Alcon announced March 12 that it had launched presbyopia-correcting intraocular lenses (IOLs) in India made of the Clareon glistening-free material. The Clareon platform is available in India in tw...

3/22/2024
BreakingClinical TrialCornealRegulation
US FDA Gives Green Light to Phase I Trial of Fuchs’ Candidate from Design Therapeutics
US FDA Gives Green Light to Phase I Trial of Fuchs’ Candidate from Design Therapeutics

Design Therapeutics reported March 19 in its 2023 financial statement that the US FDA had cleared its investigational new drug (IND) application for a clinical trial of DT-168 in Fuchs’ endothelial...

3/22/2024
BreakingIndustryRetina
Clearside Biomedical Appoints Victor Chong, MD, MBA, as Chief Medical Officer
Clearside Biomedical Appoints Victor Chong, MD, MBA, as Chief Medical Officer

Clearside Biomedical announced March 18 that it had appointed Victor Chong, MD, MBA, as chief medical officer. Chong, a retina specialist, most recently served as vice president, global head of ret...

3/21/2024
DeviceNewsletterPharmaRetinaRevenue
Ophthalmic Company Revenue in Q4-2023 Rises 0.4 Percent
Ophthalmic Company Revenue in Q4-2023 Rises 0.4 Percent

Ophthalmic manufacturer revenue in Q4-2023 totaled $11.2 billion. Revenue increased 0.4 percent from the same quarter in 2022 and increased 1.0 percent from Q3-2023. The total includes Market Scope...

Past News Stories

3/21/2024
CataractGlaucomaIOLNewsletterRetina
Ophthalmologists Report 1.8 Percent Decline in Q4-2023 Procedure Volume
Ophthalmologists Report 1.8 Percent Decline in Q4-2023 Procedure Volume

----- Refractive: -12.1 IOL: 5.4 Glaucoma: 4.8 Retina: -4.4 ----- US ophthalmologists reported that ophthalmic procedures decreased 1.8 percent in Q4-2023 compared with the same quarter in 2022, ac...

3/21/2024
CataractIOLNewsletterPremiumSurgical
Robust Premium IOL Revenue Growth Expected to Continue Through 2029
Robust Premium IOL Revenue Growth Expected to Continue Through 2029

The global intraocular lens market has shown strong growth during the past seven years, increasing from $3.8 billion in 2017 to $5.8 billion in 2023, for a compound annual growth rate of nearly 8 p...

3/21/2024
CornealGlaucomaNewsletterSurgical
CorNeat Vision Launches EverPatch Ophthalmic Graft Material in the US
CorNeat Vision Launches EverPatch Ophthalmic Graft Material in the US

Israel-based CorNeat Vision announced Feb. 27 that it had launched its EverPatch scleral reinforcement patch in the US. The device was cleared by the US FDA in June 2023. The graft is the first syn...

3/21/2024
CataractNewsletterPharmaRegulation
US FDA Approves Clobetasol Propionate Eye Drops for Postsurgical Pain, Inflammation
US FDA Approves Clobetasol Propionate Eye Drops for Postsurgical Pain, Inflammation

Taiwan-based Formosa Pharmaceuticals announced March 4 that the US FDA had approved clobetasol propionate ophthalmic suspension 0.05% (APP13007) for inflammation and pain following ocular surgery. ...

3/21/2024
Data SecurityNewsletter
Cyber Threats Worry Half of Respondents to Q2-2023 Survey, While Some Doctors Aren’t as Concerned
Cyber Threats Worry Half of Respondents to Q2-2023 Survey, While Some Doctors Aren’t as Concerned

Market Scope surveys have indicated that US ophthalmologists have had mixed opinions about the importance of data security. The recent hacking of one of the US’ biggest health care payment systems ...

3/21/2024
NewsletterPharmaRefractive
Santen Files for Marketing Approval in Japan for Atropine Drops to Delay Myopia
Santen Files for Marketing Approval in Japan for Atropine Drops to Delay Myopia

Santen Pharmaceutical announced Feb. 28 that it had filed for marketing approval in Japan for DE-127 (0.025% atropine sulfate hydrate eye drop), designed to slow the progression of myopia. The prod...

3/21/2024
DiagnosticFundingNewsletterOCT
Washington U. Gets up to $20M ARPA-H Grant to Create Portable OCT
Washington U. Gets up to $20M ARPA-H Grant to Create Portable OCT

Washington University in St. Louis, Missouri, announced Feb. 13 that one of its professors had been awarded a grant of up to $20 million from the Advanced Research Projects Agency for Health (ARPA-...

3/21/2024
NewsletterRefractiveRegulationSurgical
FTC Sends Settlement Notices to Potential Victims of Bait-and-Switch LASIK Ads
FTC Sends Settlement Notices to Potential Victims of Bait-and-Switch LASIK Ads

The Federal Trade Commission has sent notices to about 160 thousand individuals who received LASIK consultations at LasikPlus or Joffe MediCenter that they may be eligible for a settlement payout. ...

3/21/2024
CataractDiagnosticGlaucomaNewsletterRefractiveRegulationRetinaSurgical
Select US FDA Approvals and Clearances in February 2024
Select US FDA Approvals and Clearances in February 2024

The US FDA granted two clearances through the ophthalmic device division using the 510(k) pathway in February 2024, according to the agency’s database. CATS Tonometer received clearance for its ton...

3/21/2024
GlaucomaNewsletterPharmaSurgical
Celanese Announces Launch of Glaukos’ iDose TR Travoprost Implant
Celanese Announces Launch of Glaukos’ iDose TR Travoprost Implant

Celanese announced the commercial launch Feb. 29 of Glaukos’ iDose TR intracameral travoprost implant for glaucoma. Celanese, a specialty materials and chemical company based in Dallas, Texas, prod...

3/21/2024
CataractIOLIndiaNewsletterSurgical
Alcon’s Vivity EDOF IOL Reaches Milestone of 1 Million Implantations
Alcon’s Vivity EDOF IOL Reaches Milestone of 1 Million Implantations

Alcon reported March 6 that the AcrySof IQ Vivity and Clareon Vivity extended depth of focus (EDOF) intraocular lenses (IOLs) had surpassed more than 1 million implantations worldwide. According to...

3/21/2024
CataractMeetingNewsletterSurgical
Meet with Market Scope at the 2024 ASCRS Meeting
Meet with Market Scope at the 2024 ASCRS Meeting

Market Scope will be located at Booth 3080 at the 2024 ASCRS meeting in Boston, set for April 5-8. Contact us to set up a time to discuss your custom research needs and to learn about our new repor...

Want to Read the Full Article?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more